Minor extended-spectrum β-lactamases

被引:155
|
作者
Naas, T. [1 ]
Poirel, L. [1 ]
Nordmann, P. [1 ]
机构
[1] Univ Paris 11, Fac Med, Assistance Publ Hop Paris, Hop Bicetre,Serv Bacteriol Virol, F-94275 Le Kremlin Bicetre, France
关键词
extended spectrum beta-lactamase; ESBL; non-CTX-M; non-SHV; non-TEM; OXA ESBL; oxacillinase; review;
D O I
10.1111/j.1469-0691.2007.01861.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Extended-spectrum beta-lactamases (ESBLs) are usually plasmid-mediated enzymes that confer resistance to a broad range of beta-lactams. Initially, resistance to third-generation cephalosporins in Gram-negative rods was mainly due to the dissemination of TEM- and SHV-type ESBLs, which are point mutants of the classic TEM and SHV enzymes with extended substrate specificity. During the last ten years, CTX-Mtype ESBLs have become increasingly predominant, but less frequent class A beta-lactamases have also been described, including SFO, BES, BEL, TLA, GES, PER and VEB types. While several of these latter are rarely identified, or are very localised, others are becoming locally prevalent, or are increasingly isolated worldwide. In addition, mutations can extend the spectrum of some OXA-type beta-lactamases to include expanded-spectrum cephalosporins, and several of these enzymes are considered to be ESBLs.
引用
收藏
页码:42 / 52
页数:11
相关论文
共 50 条
  • [1] Minor extended-spectrum β-lactamases
    Akinci, Esragul
    Vahaboglu, Haluk
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (11) : 1251 - 1258
  • [2] Extended-spectrum β-lactamases
    Turner, PJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 : S273 - S275
  • [3] Extended-spectrum beta-lactamases
    Philippon, A.
    [J]. IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2013, 28 (5-6): : 287 - 296
  • [4] Extended-spectrum β-lactamases:: a clinical update
    Paterson, DL
    Bonomo, RA
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (04) : 657 - +
  • [5] Clinical significance of extended-spectrum β-lactamases
    Rodriguez-Bano, Jesus
    Pascual, Alvaro
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (05) : 671 - 683
  • [6] Genetic support of extended-spectrum β-lactamases
    Poirel, L.
    Naas, T.
    Nordmann, P.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 75 - 81
  • [7] Extended-spectrum β-lactamases and the permeability barrier
    Martinez-Martinez, L.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 82 - 89
  • [8] EXTENDED-SPECTRUM BETA-LACTAMASES
    PHILIPPON, A
    LABIA, R
    JACOBY, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) : 1131 - 1136
  • [9] Extended-spectrum beta-lactamases
    Patterson, JE
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 24 (01) : 79 - 87
  • [10] Extended-spectrum β-lactamases in Pseudomonas aeruginosa
    Nordmann, P
    Guibert, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) : 128 - 131